Skip to main content

Table 1 Summary of CI value and the concentration of separate drugs in combination at 50% Fa

From: Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway

Drug combination

Fa = 0.5

EJ

T24

BIU

5637

Cisplatin + matrine

 CI regimen

0.66585 ± 0.09929

0.66555 ± 0.02893

0.676608 ± 0.13417

0.51106 ± 0.06219

 Cisplatin (μM)

0.91083

0.97855

0.63823

0.76946

 Matrine (mM)

1.82166

1.95910

1.27646

1.53892